Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Danyelza (naxitamab) / Y-mAbs Therap

NCT02307630: PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study

Active, not recruiting

N/A

124I-Humanized 3F8

Memorial Sloan Kettering Cancer Center, Y-mAbs Therapeutics

Melanoma, Neuroblastoma, Sarcoma

11/24

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites